Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial

Fig 2

Incidence of secondary outcomes in the ITT population.

aDenominators are the number of subjects with a premature or full-term live birth and a non-missing birth weight. bDenominators are the number of pregnancy outcomes, excluding those that were unknown/missing. cIncluding neonatal death and congenital malformations. dDenominators are the number of subjects with a premature or full-term live birth. eDenominators are the number of subjects with available measurements. fSTI = sexually transmitted infection between first dose and Week 36 to 38 of gestation including T. pallidum, N. gonorrhoeae, C. trachomatis (diagnosed based on clinical presentation prior to week 36–38 and/or positive lab test results between week 36–38). gDiagnosed based on positive result at week 36 to 38 of gestation. hBetween first dose and delivery

Fig 2